Biotech · Private company
Minneamrita Therapeutics LLC
Track this companyFree. Adds Minneamrita Therapeutics LLC to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- MinnelidePhase 2 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- Minnelide™CapsulesPhase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid LeukemiaPHASE1 · TERMINATED · started Apr 18, 2019ClinicalTrials.gov NCT03760523 · fetched Nov 12, 2026
- A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid TumorsPHASE1 · UNKNOWN · started Oct 10, 2017ClinicalTrials.gov NCT03129139 · fetched Nov 12, 2026
- A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic CancerPHASE2 · COMPLETED · started Apr 10, 2017ClinicalTrials.gov NCT03117920 · fetched Nov 12, 2026